https://www.selleckchem.com/pr....oducts/pmsf-phenylme
id-dependent oxidative stress and inflammatory response. These events were associated with dyslipidaemia and increased atherogenic indices. This infers that regular monitoring of glucose level, insulin sensitivity, lipid profile, and oxido-inflammatory markers is important in patients on antikoch and/or HAART for prompt diagnosis and management of cardiometabolic disorder if it ensues. This study provides the first evidence that antikoch and/or HAART induce cardiometabolic dysfunction via glutathione suppressi